Neostigmine Methylsulfate
NDC 43598-945, Neostigmine Methylsulfate, injection, solution, from Dr.Reddys Laboratories Inc.
- Product NDC
- 43598-945
- Status
- Listed
- Labeler
- Dr.Reddys Laboratories Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216291
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43598-945 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NEOSTIGMINE METHYLSULFATE1 mg/mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43598-945-58 | 43598094558 | 10 BLISTER PACK in 1 CARTON (43598-945-58) / 1 SYRINGE, GLASS in 1 BLISTER PACK (43598-945-11) / 3 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/12575d1a-a2c2-37b2-0dcf-31e58bbc2a10
Use it
Look up 43598-945 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43598-945 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43598-945. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.